Literature DB >> 24211862

Hemorrhagic retinal infarction due to inadvertent overdose of cefuroxime in cases of complicated cataract surgery: retrospective case series.

Süleyman Çiftçi1, Leyla Çiftçi2, Umut Dağ3.   

Abstract

PURPOSE: To present 4 patients that developed hemorrhagic retinal infarction attributable to inadvertent overdose of cefuroxime after cataract surgery.
DESIGN: Case series. SUBJECTS AND METHODS: Surgery in 4 patients was complicated-the posterior capsule was absent or torn-and anterior vitrectomy was performed. Cefuroxime was inadvertently injected at a dose higher than recommended in all 4 cases.
RESULTS: Case 1 had hemorrhage in the central and inferior retinal regions, as well as optic atrophy. Case 2 had hemorrhage in the peripapillary and macular regions, as well as optic atrophy. Case 3 had hemorrhage in the peripapillary and inferior retinal regions, as well as macular pucker attributable to fibrovascular formation in the central retinal region. Case 4 had hemorrhage in the peripapillary, macular, and inferior retinal regions. The cefuroxime doses administered to the presented patients were much higher than reported in other cases and resulted in a higher concentration in the vitreous. Consequently, the severity of toxicity was much higher than in other reported cases of cefuroxime-induced toxicity.
CONCLUSION: In cases of intracameral cefuroxime overdose, hemorrhagic retinal infarction can develop after cataract surgery.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24211862     DOI: 10.1016/j.ajo.2013.10.018

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Retinal toxicity secondary to subconjunctival cefuroxime following pars plana vitrectomy: A case report and literature review.

Authors:  Antony Raharja; James E Neffendorf; Tom H Williamson
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-02

2.  Transient macular edema after intracameral injection of a moderately elevated dose of cefuroxime during phacoemulsification surgery.

Authors:  David C Wong; Michael D Waxman; Lisa J Herrinton; Neal H Shorstein
Journal:  JAMA Ophthalmol       Date:  2015-10       Impact factor: 7.389

3.  Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis.

Authors:  Christine Purslow; Keith Davey; Mildred Johnson; Guilhem Pietri; Gaurav Suri
Journal:  BMC Ophthalmol       Date:  2015-07-08       Impact factor: 2.209

Review 4.  Risks of Cefuroxime Prophylaxis for Postcataract Endophthalmitis.

Authors:  Khaled A Al-Abduljabbar; Donald U Stone
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Jan-Mar

5.  Intracameral cefuroxime in combined pars plana vitrectomy and phacoemulsification: a study of safety.

Authors:  Gianluca Besozzi; Attilio Di Salvatore; Daniele Cardillo; Alessandro Finzi; Joseph Sajish Pinackatt; Andrea Baldi; Alessandro Monfardini; Valeria Forioli; Rino Frisina; Barbara Parolini
Journal:  Clin Ophthalmol       Date:  2018-08-28

6.  Toxicities of and inflammatory responses to moxifloxacin, cefuroxime, and vancomycin on retinal vascular cells.

Authors:  Hitomi Miyake; Dai Miyazaki; Yumiko Shimizu; Shin-Ichi Sasaki; Takashi Baba; Yoshitsugu Inoue; Kazuki Matsuura
Journal:  Sci Rep       Date:  2019-07-05       Impact factor: 4.379

7.  High dose cefuroxime causing retinal toxicity in a patient undergoing trabeculectomy.

Authors:  Jae Yee Ku; Shiao Wei Wong; Laura R Steeples; Claire Delaney; Neil R A Parry; Cecilia Fenerty
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-02

8.  Development of Retinal Infarct Due to Intracameral Cefuroxime Injection Following Complicated Cataract Surgery

Authors:  Sabahattin Sül; Aylin Karalezli
Journal:  Turk J Ophthalmol       Date:  2018-12-27

Review 9.  Postoperative Endophthalmitis and Toxic Anterior Segment Syndrome Prophylaxis: 2020 Update.

Authors:  Jesse D Sengillo; Ying Chen; Diley Perez Garcia; Stephen G Schwartz; Andrzej Grzybowski; Harry W Flynn
Journal:  Ann Transl Med       Date:  2020-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.